Article
PILRA regulates microglial immunometabolism to reduce disease pathology as a candidate therapeutic target for Alzheimer’s disease
2025-03-12
Abstract excerpt
<title>Abstract</title> <p> The Alzheimer’s disease (AD) genetic landscape identified microglia as a key disease-modifying cell type. A known AD protective variant in paired immunoglobulin-like type 2 receptor alpha (PILRA), shown to reduce risk in APOE4 carriers, is enriched in a cohort of healthy centenarians; however, mechanisms underlying protective effects in microglia are undefined. Here we identify biolog...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 02754854-4d1e-57cc-9f3b-b8ab7257148f
- DOI
- 10.21203/rs.3.rs-3954863/v2
